Van Assche, Gert <br/><br/>
Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn's disease.  [electronic resource] 

 -  Journal of Crohn's & colitis  Dec 2013 
 - 950-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1876-4479 
<br/><br/><label>Standard No.: </label>10.1016/j.crohns.2013.01.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Inflammatory Agents, Non-Steroidal--adverse effects<br/>Antibodies, Monoclonal--adverse effects<br/>C-Reactive Protein--metabolism<br/>Contrast Media<br/>Crohn Disease--blood<br/>Female<br/>Gadolinium<br/>Humans<br/>Ileitis--blood<br/>Infliximab<br/>Magnetic Resonance Imaging<br/>Male<br/>Middle Aged<br/>Severity of Illness Index<br/>Time Factors<br/>Young Adult